Search
Turn Therapeutics Ord Shs
TTRXAdd to Watchlist
4.050USD
+0.030+0.75%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
120.64MMarket Cap
LossP/E TTM
More Details of Company
Turn Therapeutics Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Turn Therapeutics Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Arthur F. Golden
Mr. Arthur F. Golden
Independent Director Nominee
Independent Director Nominee
360.60K
+83.19%
Mr. Zuraiz Chaudhary
Mr. Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
12.50K
--
Dr. Kent Kester
Dr. Kent Kester
Independent Director Nominee
Independent Director Nominee
10.00K
--
Mr. Bradley Burnam
Mr. Bradley Burnam
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Andrew Gengos
Mr. Andrew Gengos
Independent Director
Independent Director
--
--
Dr. Neilesh Shailesh (Neil) Ghodadra
Dr. Neilesh Shailesh (Neil) Ghodadra
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Arthur F. Golden
Mr. Arthur F. Golden
Independent Director Nominee
Independent Director Nominee
360.60K
+83.19%
Mr. Zuraiz Chaudhary
Mr. Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
12.50K
--
Dr. Kent Kester
Dr. Kent Kester
Independent Director Nominee
Independent Director Nominee
10.00K
--
Mr. Bradley Burnam
Mr. Bradley Burnam
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Andrew Gengos
Mr. Andrew Gengos
Independent Director
Independent Director
--
--
Dr. Neilesh Shailesh (Neil) Ghodadra
Dr. Neilesh Shailesh (Neil) Ghodadra
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BEB Holdings LLC
52.76%
Golden (Arthur F)
1.21%
Millennium Management LLC
0.32%
DDFG, Inc
0.24%
Wellington Shields & Co. LLC
0.22%
Other
45.25%
Shareholders
Shareholders
Proportion
BEB Holdings LLC
52.76%
Golden (Arthur F)
1.21%
Millennium Management LLC
0.32%
DDFG, Inc
0.24%
Wellington Shields & Co. LLC
0.22%
Other
45.25%
Shareholder Types
Shareholders
Proportion
Corporation
52.76%
Individual Investor
1.36%
Investment Advisor
0.79%
Hedge Fund
0.39%
Research Firm
0.33%
Venture Capital
0.08%
Bank and Trust
0.08%
Investment Advisor/Hedge Fund
0.06%
Other
44.14%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
2
71.61K
0.06%
--
2026Q1
27
602.44K
2.02%
+388.67K
2025Q4
9
209.03K
0.71%
+191.89K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BEB Holdings LLC
16.02M
54.39%
+16.02M
--
Oct 08, 2025
Golden (Arthur F)
60.60K
0.21%
+30.40K
+100.66%
Nov 24, 2025
Millennium Management LLC
95.62K
0.32%
+95.62K
--
Dec 31, 2025
DDFG, Inc
52.29K
0.18%
+52.29K
--
Dec 31, 2025
Wellington Shields & Co. LLC
65.73K
0.22%
+65.73K
--
Dec 31, 2025
XTX Markets LLC
25.17K
0.09%
+25.17K
--
Dec 31, 2025
Brown Brothers Harriman & Company
23.69K
0.08%
+23.69K
--
Dec 31, 2025
Dewhurst (Martin William)
21.88K
0.07%
+21.88K
--
Jan 07, 2026
Citadel Advisors LLC
20.99K
0.07%
+20.99K
--
Dec 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
